Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma-MedSci.cn

Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma

Li, MQ

Li, MQ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Li, MQ (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.

LANCET ONCOLOGY, 2021; 22 (8): E342

科室
- - 订阅+
  - 更多科室
工具
服务